DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20175450

Glycosylated hemoglobin and left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus

Vishal S. Yesankar, Nalini R. Humaney

Abstract


Background: Diabetes mellitus is one of the most common diseases. Left ventricular diastolic dysfunction may represent the early stage of diabetic cardiomyopathy thus reinforcing the importance of the early examination of diastolic function in individuals with diabetes.

Methods: This is a hospital based cross-sectional study done at a tertiary care hospital catering mainly to rural population. Patients having type 2 diabetes mellitus were scrutinized for doppler echocardiography and HbA1c levels. As per the previous studies and considering the prevalence of asymptomatic diastolic dysfunction in diabetics, the sample size was calculated. Statistical analysis was done by using descriptive and inferential statistics using chi square test.

Results: In the present study 45 patients had HbA1C between 6.5- 8.0, out of which 9 had type I diastolic dysfunction, 1 had type II diastolic dysfunction and 35 had no diastolic dysfunction. 16 patients had HbA1C between 8.1- 9.5, out of which 7 had type I diastolic dysfunction, 8 had type II diastolic dysfunction and 1 had no diastolic dysfunction. 14 patients had HbA1C more than 9.5, out of which 4 had type I diastolic dysfunction, 5 had type II diastolic dysfunction, 4 had type III diastolic dysfunction and 1 patient did not had any diastolic dysfunction. The Chi-Square value is 55.51 and p value is 0.000 (Significant).

Conclusions: Diastolic dysfunction correlates with the levels of glycosylated hemoglobin, duration of diabetes mellitus, presence of microvascular complications like diabetic retinopathy, neuropathy and nephropathy.


Keywords


Cardiomyopathy, Diabetes, Diastolic dysfunction, Glycosylated hemoglobin

Full Text:

PDF

References


Howard BV, Rodlriguez BL, Bennet PH, Harris MI, Hamman,R, Prevention conference VI:diabetes and cardiovascular disease: writing group I; epidemiology, Circulation 2002;105;132-7

Garcia MJ, Mcnamara PM, Gordon T.16 year follow up study: morbidity and mortality in diabetes in the Framingham population diabetes. Am J Cardiol 1976;23:105.

Diamant M, Lamb HJ, Endert EL, Smit WA, Bax JJ, Romijn JA, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled Type 2 diabetes mellitus. J Am Coll Cardiol 2003;42:328–35

ACC/AHA/ASE 2003 guidelines update for the clinical application of echocardiography: a report of American college of cardiology/American Heart association Task Force on Practice Guidelines (ACC/AHA/ASE committee to update the 1997 Guideline for the clinical application of echocardiography). J Am Coll Cardiol 2003;42:957–70.

Mehrdad S, Zoleikha J. Relation of HbA1c to left ventricular diastolic function in patients with type 1 diabetes mellitus and without overt heart disease. Diabetologia Croatica 2006;24:35–7.

Wojciech K, Monika PK, Walentyna M. Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am J Cardiol 2004;94:395–9.

Mehdi HS, Byron JH, Paul S, Steven PM, Jing PS, Jianbo L, et al. Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease. Am J Cardiol 2003;19:1514–7.

Miguel Z, Magdy F, Ismail, Lori A, Fathi A. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well controlled type 2 diabetes mellitus. Am J Cardiol 2001;87:320–3.

Liu JE, Palmieri V, Roman MJ, Bella JN, Rabsitz R, Howard BV, et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: The Strong Heart Study. J Am Cardiol 2001;37:1943–9.

Markuszewski L, Gycewicz T, Pietruszynski R, Michalkiewicz D, Roszczyk N. Glycosylated hemoglobin and left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus. Pol Merkur Lekarski 2006;21:8–11.